• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

CLINICAL CASES IN MS – A case of worsening mobility during the pandemic

May 16, 2023  

AAN update on anti-CD20 agents: long-term data

May 10, 2023  

Emerging role of CHI3L1 as MS biomarker

May 2, 2023  

sNfL a biomarker of future disease activity: APLIOS

April 12, 2023  

Is vitamin D supplementation justified?

April 5, 2023  

CLINICAL CASES IN MS – A YOUNG WOMAN WITH BREAKTHROUGH DISEASE ON FINGOLIMOD

March 29, 2023  

Putting biomarkers into practice

March 8, 2023  

CNS effects of Wegovy (semaglutide)

February 28, 2023  

Putting shared decision-making into practice

February 16, 2023  

CLINICAL CASES IN MS – AN OLDER PATIENT WITH STABLE DISEASE

February 9, 2023  
1
2
3
Next

Browse by Topic

MS (341)
AD (82)
PD (78)
COVID-19 (58)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
MIGRAINE (26)
SCHIZOPHRENIA (25)
EPILEPSY (22)
STROKE (22)
BIOMARKERS IN MS (20)
Library (13)
ECTRIMS 2015 (13)
AAN 2015 (11)
ECTRIMS 2019 (10)
ECTRIMS 2021 (10)
CLINICAL CASES IN MS (10)
ECTRIMS 2014 (10)
DEMENTIA (10)
ECTRIMS 2018 (9)
MS SEQUENCING (9)
AAN 2013 (9)
AAN 2014 (9)
ECTRIMS 2013 (9)
PSYCHIATRY (8)
AAN 2019 (7)
ACTRIMS-ECTRIMS 2020 (7)
AAN 2021 (6)
ECTRIMS 2017 (6)
CHARCOT 2013 (6)
ECTRIMS 2022 (6)
ANXIETY (5)
ECTRIMS 2016 (5)
AAN 2022 (5)
BIPOLAR (5)
CCSVI (5)
BPD (4)
NeuroSound (4)
AAN 2023 (4)
EAN 2015 (4)
ENS 2013 (3)
PAIN (3)
AAN 2017 (3)
EAN 2022 (3)
AAN 2020 (3)
SLEEP (2)
EAN 2020 (2)
APA 2014 (2)
SPECIAL REPORT (2)
AAN 2018 (2)
NEW DRUGS (2)
EAN 2021 (1)
SEIZURE (1)
ACTRIMS 2022 (1)
APA 2016 (1)
LGS (1)
TSC (1)
LUMBAR PUNCTURE (1)
ACTRIMS 2023 (1)
ALS (1)
hATTR (1)
INSOMNIA (1)
Dravet syndrome (1)
CIDP (1)
CONCUSSION (1)
ADDICTION (1)
EAN 2019 (1)
AAN 2016 (1)
WEST NILE (1)
GUIDELINES (1)
EAN 2016 (0)
BIOMARKERS (0)
ECTRIMS 2020 (0)
View all Topics

Popular Posts

  • CNS effects of Wegovy (semaglutide) posted on February 28, 2023
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Progression independent of relapses (PIRA) in MS posted on November 21, 2019
Copyright 2023 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions